Cell Death & Disease, 2018 · DOI: 10.1038/s41419-018-0847-8 · Published: August 1, 2018
This research investigates the potential of menstrual blood-derived stem cells (MenSCs) to aid recovery after spinal cord injury (SCI) in rats. SCI often leads to permanent motor and sensory deficits due to the limited regeneration of damaged axons. The study found that transplanting MenSCs into rats with incomplete spinal cord injuries improved their hind limb motor function and reduced cavity formation at the injury site. MenSCs treatment also showed more mature neurons. The researchers found that MenSCs transplantation promoted axon growth, reduced glial scar formation, and enhanced the expression of brain-derived neurotrophic factor (BDNF), a protein crucial for neuron survival and growth, in the injured area.
MenSCs could be a readily accessible and ethically less problematic source of stem cells for treating spinal cord injuries.
The study highlights the role of BDNF in the therapeutic effects of MenSCs, providing insights into the mechanisms of spinal cord repair.
Further studies are needed to evaluate the long-term efficacy and safety of MenSCs transplantation in larger animal models and eventually in clinical trials.